Aranda, Selena
Jiménez, Esther
Canales-Rodríguez, Erick J.
Verdolini, Norma
Alonso, Silvia
Sepúlveda, Esteban http://orcid.org/0000-0003-3039-0022
Julià, Antonio http://orcid.org/0000-0001-6064-3620
Marsal, Sara
Bobes, Julio http://orcid.org/0000-0003-2187-4033
Sáiz, Pilar A.
García-Portilla, Paz
Menchón, Jose M. http://orcid.org/0000-0002-6231-6524
Crespo, José M.
González-Pinto, Ana
Pérez, Víctor
Arango, Celso http://orcid.org/0000-0003-3382-4754
Sierra, Pilar
Sanjuán, Julio
Pomarol-Clotet, Edith
Vieta, Eduard http://orcid.org/0000-0002-0548-0053
Vilella, Elisabet http://orcid.org/0000-0002-1887-5919
Article History
Received: 28 August 2023
Revised: 1 February 2024
Accepted: 5 February 2024
First Online: 19 February 2024
Competing interests
: Eduard V has received grants and served as consultant, advisor, or CME speaker (unrelated to this work) for the following entities: AB-Biotics, Abbott, AbbVie, Angelini, Biogen, Compass, Dainippon Sumitomo Pharma, Ferrer, Gedeon Richter, Glaxo Smith-Kline, GH Research, Janssen, Lundbeck, Otsuka, Sage, Sanofi-Aventis, Sunovion, Takeda, and Viatris. AGP has received grants and served as a consultant, advisor or CME speaker for the following entities: Janssen-Cilag, Lundbeck, Otsuka, Pfizer, Sanofi-Aventis, Alter, Angelini, Exeltis, Novartis, Rovi, Takeda, the Spanish Ministry of Science and Innovation (CIBERSAM), the Ministry of Science (Carlos III Institute), the Basque Government, and the European Framework Program of Research. The other authors have no conflicts of interest to disclose. CA received support from the Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (ISCIII), co-financed by the European Union, and ERDF Funds from the European Commission, “A way of making Europe”, financed by the European Union - NextGenerationEU (PMP21/00051), PI19/01024, CIBERSAM, Madrid Regional Government (B2017/BMD-3740 AGES-CM-2), European Union Structural Funds, European Union Seventh Framework Program, European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking: Project PRISM-2 (Grant agreement No.101034377), Project AIMS-2-TRIALS (Grant agreement No. 777394), Horizon Europe, the National Institute of Mental Health of the National Institutes of Health under Award Number 1U01MH124639–01 (Project ProNET) and Award Number 5P50MH115846–03 (project FEP-CAUSAL), Fundación Familia Alonso, and Fundación Alicia Koplowitz.